Cargando…
The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
Autores principales: | Sawyer, S, Boyle, S, Young, MA, Kovalenko, S, Doherty, R, McKinley, J, Alsop, K, Rehfisch, M, Macaskill, S, Ha, A, Beshay, V, Lindeman, G, Harris, M, Fox, S, Mitchell, G, James, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327262/ http://dx.doi.org/10.1186/1897-4287-10-S2-A89 |
Ejemplares similares
-
Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012) -
Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
por: Bielecka, Helena, et al.
Publicado: (2012) -
Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012) -
Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007) -
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)